163P Epidemiological profile of breast cancer in Morocco: First results from the Reference Center for Reproductive Health in Kenitra

Abstract

Since the implementation of the Breast and Cervical Cancer Early Detection Program in late 2012 in the former region of Gharb-Chrarda-Béni Hssen, a marked improvement has been observed in terms of breast cancer screening and diagnosis. The aim of this study is to describe the epidemiological profile of breast cancer in this region in Morocco. This is a descriptive retrospective study of women screened for breast cancer in public and private health establishments in Kenitra, Sidi Kacem and Sidi Slimane, referred for investigation at the Reference Center for Reproductive Health in Kenitra (RCRHK) between January 1, 2013 and December 31, 2018. During the period 2013-2018, 973 new cases of breast cancer were diagnosed in women at the RCRHK, of which 62% were aged between 40 and 59 years. The average age at diagnosis of breast cancer was 51.15 ± 12 years. According to the results, 67% came from Kenitra and 65% lived in urban areas. Almost two-thirds (66%) of women were married. According to the data recorded, 55% benefited from the Medical Assistance Scheme (RAMED) and 22% had no social security coverage. The average age at first pregnancy was 24 ± 6.9 years, with an average of 4.32 pregnancies and 3.76 live births per woman. More than half (55%) of the women were postmenopausal and 54% used hormonal contraception. Nearly 7% of women had a personal history and 13% had a family history of breast disease. Invasive breast carcinoma was the most common histological type of breast cancer, with 88% of cases. According to the results, unilateral breast cancer was more frequent in the left breast than in the right. It should be noted that 67% of the lesions were classified as BI-RADS 5. The epidemiological surveillance of breast cancer will contribute to the revision, or consolidation of strategic axes of the National Breast Cancer Early Detection Program, in order to reduce morbidity and mortality due to cancer, and provide optimal care for cancer patients.